🇺🇸 FDA
Patent

US 7824682

Cardiac myosin light chain kinase-specific antibodies and methods of detecting

granted A61KA61K38/00A61P

Quick answer

US patent 7824682 (Cardiac myosin light chain kinase-specific antibodies and methods of detecting) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K38/00, A61P, A61P9/04